Geron | GERN - L'Utile Ante Imposte

Prezzo Delle Azioni
1.59
Cambio Giornaliero
0.13 8.56%
Mensile
-18.72%
Annuale
-9.43%
Q1 Previsione
1.42




L'Utile Ante Imposte Cambiamento Data
Amgen USD 3.92B 2.35B 2025-09
Bio Techne USD 84.99M 107.85M 2025-09
Cassava Sciences USD -10.81M 33.41M 2025-09
Cytokinetics USD -183.03M 123.15M 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Exelixis USD 252.69M 275K 2025-12
Genmab DKK 55M 427M 2025-12
Geron USD -31.14M 12.72M 2025-12
Gilead Sciences USD 3.64B 1.21B 2025-09
Incyte USD 389.94M 92.37M 2025-12
MacroGenics USD -14.93M 31.75M 2025-12
Novartis USD 4.64B 445M 2025-12
Novavax USD 17.9M 220.94M 2025-12